4//SEC Filing
Goldberg Andrew D. 4
Accession 0001819790-23-000058
CIK 0001819790other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:56 PM ET
Size
7.9 KB
Accession
0001819790-23-000058
Insider Transaction Report
Form 4
Goldberg Andrew D.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+5,000→ 5,000 totalExercise: $17.99Exp: 2033-06-21→ Common Stock (5,000 underlying) - Award
Restricted Stock Units
2023-06-22+3,350→ 3,350 total→ Common Stock (3,350 underlying)
Footnotes (3)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827722
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:56 PM ET
- Size
- 7.9 KB